bromine has been researched along with Leukemia L 1210 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballmaier, D; Epe, B | 1 |
| Glazman-Kuśnierczyk, H; Matuszyk, J; Radzikowski, C | 1 |
| Carter, SK | 1 |
| Hansen, HH; Keyes, JW; Selawry, OS | 1 |
| Acton, EM; Christensen, JE; Goodman, L; Keyanpour-Rad, M; Kwok, RP; Tong, HH | 1 |
| Huennekens, FM; Reyes, P | 1 |
| Baker, BR; Lourens, GJ | 2 |
2 trial(s) available for bromine and Leukemia L 1210
| Article | Year |
|---|---|
Dibromodulcitol (NSC-104800)--clinical brochure.
Topics: Animals; Antineoplastic Agents; Bromine; Carbohydrates; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dogs; Female; Haplorhini; Humans; Leukemia L1210; Mice | 1968 |
Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
Topics: Adult; Aged; Alkylating Agents; Animals; Blood Platelets; Bone Marrow; Bromine; Carcinoma, Squamous Cell; Clinical Trials as Topic; Dogs; Drug Tolerance; Evaluation Studies as Topic; Galactitol; Haplorhini; Hodgkin Disease; Humans; Leukemia L1210; Leukopenia; Male; Middle Aged; Neoplasms; Sugar Alcohols; Thrombocytopenia | 1971 |
6 other study(ies) available for bromine and Leukemia L 1210
| Article | Year |
|---|---|
Oxidative DNA damage induced by potassium bromate under cell-free conditions and in mammalian cells.
Topics: Animals; Bromates; Bromine; Carcinogens; Cattle; Cell-Free System; Cells, Cultured; DNA Damage; DNA, Viral; Free Radical Scavengers; Free Radicals; Glutathione; Guanine; Hydroxyl Radical; Kidney; Leukemia L1210; Mice; Oxidation-Reduction; Reactive Oxygen Species | 1995 |
Antitumor activity evaluation of bromine-substituted analogues of ifosfamide. I. Stereodifferentiation of biological effects and selection of the most potent compounds.
Topics: Animals; Bromine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Ifosfamide; Lethal Dose 50; Leukemia L1210; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms, Experimental; Stereoisomerism; Structure-Activity Relationship | 1992 |
Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
Topics: Acetals; Animals; Antineoplastic Agents; Bromine; Carcinoma 256, Walker; Chlorine; Deuterium; Fluorine; Iodine; Leukemia L1210; Magnetic Resonance Spectroscopy; Mannitol; Mice; Rats; Stereoisomerism; Sugar Alcohols; Sulfones; Sulfonic Acids; Tosyl Compounds | 1972 |
Ion-dependent activation of dihydrofolate reductase from L1210 cells.
Topics: Animals; Binding Sites; Bromine; Chlorine; Folic Acid Antagonists; Hydrogen-Ion Concentration; Ions; Kinetics; Leukemia L1210; Male; Mice; Neoplasms, Experimental; Stimulation, Chemical; Tetrahydrofolate Dehydrogenase; Urea | 1967 |
Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
Topics: Amides; Amines; Animals; Benzene Derivatives; Binding Sites; Bromine; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Chlorine; Columbidae; Fluorine; Folic Acid Antagonists; Leukemia L1210; Liver; Methods; Mice; Rats; Sulfonic Acids; Tetrahydrofolate Dehydrogenase; Triazines | 1968 |
Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
Topics: Amides; Amines; Animals; Benzene Derivatives; Binding Sites; Bromine; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Columbidae; Folic Acid Antagonists; Leukemia L1210; Liver; Methods; Mice; Rats; Tetrahydrofolate Dehydrogenase; Triazines | 1968 |